|
|
|
|
|
|
CHI's Fourteenth
Molecular Medicine Tri-Conference delivered more CONTENT,
PARTICIPANTS, NETWORKING and EXHIBITORS than ever before. This
year?s event provided a truly unique content-driven experience
delivering newly expanded content that created quite a buzz
onsite. There was great excitement over featured coverage on
outsourcing and globalization of chemistry, DMPK and clinical
trial activities in Asia and there continued to be a high
energy from the diagnostic and therapeutic development
participants attending the Molecular Diagnostics and Pathway
Analysis tracks. And not to be out done was The Stem Cell
Research conference featuring an all-new solutions driven
format.
|
Iain D. Dukes, President
& CEO, Essentialis Inc. | |
|
|
Stephen A. Williams,
M.D., Ph.D., Executive Director & Worldwide Head, Clinical Technology &
R&D, Pfizer Inc. | |
|
|
|
|
Edward G. Heidig,
General Counsel and Deputy Secretary, Business, Transportation and Housing
Agency | |
|
Length: 00:30:31
Size: 20.9
MB |
|
Length: 00:31:08
Size: 21
MB |
|
Length: 00:18:35
Size: 12.7
MB |
|
Length: 00:14:09
Size:
9.7
MB |
The confluence of Biology,
Chemistry and Business was noticeable during the multiple
networking opportunities at the event.
|
Click a
thumbnail image below to view full size
|
Over 2400 participants marked
the highest attendance in the events 14 year history.
The Exhibit hall was alive
with attendee's viewing the latest tools, technologies
and services. With over 20 new products released there
was a lot new to see.
|
Click
a thumbnail image below to view full size
|
|
|
|
|
|
|
|
right_nav.jpg
|
